Prioritizing Hits with Appropriate Trade-Offs Between Hiv-1 Reverse Transcriptase Inhibitory Efficacy and Mt4 Blood Cells Toxicity Through Desirability-Based Multiobjective Optimization and Ranking
AuthID
P-003-81T
P-003-81T